• Thumbnail for Sinopharm WIBP COVID-19 vaccine
    The Sinopharm WIBP COVID-19 vaccine, also known as WIBP-CorV, is one of two inactivated virus COVID-19 vaccines developed by Sinopharm. Peer-reviewed results...
    10 KB (1,003 words) - 16:40, 27 January 2024
  • Sanofi–GSK. Seven others are under assessment by the WHO: Sputnik V, Sinopharm WIBP, Abdala, Zifivax, Corbevax, COVIran Barekat, and SCB-2019. Of the...
    322 KB (19,558 words) - 03:33, 16 September 2024
  • Thumbnail for Sinopharm BIBP COVID-19 vaccine
    The Sinopharm BIBP COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two whole inactivated virus COVID-19...
    90 KB (8,570 words) - 16:40, 27 January 2024
  • Thumbnail for Sinopharm (company)
    deep-freeze facilities and trucks. BIBP-CorV could be transported and stored at normal refrigerated temperatures. BBIBP-CorV is being used in vaccination campaigns...
    17 KB (1,214 words) - 12:47, 25 August 2024
  • Thumbnail for COVID-19 vaccine clinical research
    Minhai-Kangtai, QazVac, Sinopharm BIBP, WIBP, Turkovac, and VLA2001. six viral vector vaccines: Sputnik Light, Sputnik V, Oxford–AstraZeneca, Convidecia, Janssen...
    95 KB (18,965 words) - 23:35, 15 September 2024
  • Thumbnail for COVID-19 vaccination in mainland China
    received a booster dose. In June 2020, the Sinopharm BIBP vaccine (BBIBP-CorV) was authorized for emergency use in China. On 22 July, Chinese authorities...
    33 KB (2,304 words) - 23:37, 15 September 2024
  • (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The first case in Nepal was confirmed on 23 January 2020 when a 31-year-old...
    180 KB (23,898 words) - 14:59, 19 August 2024